CRP and COVID-19: Indeed, NETs release has been associated with several clinical biomarkers, including acute-phase reactants (CRP and D-dimer) and inflammatory cytokines [37,38], in COVID-19 patients and is rendered a prognostic marker for diseases severity [39].